Jesús
San Miguel Izquierdo
Consultor Investigador
Leiden University Medical Center
Leiden, HolandaPublications en collaboration avec des chercheurs de Leiden University Medical Center (3)
2017
-
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
Leukemia, Vol. 31, Núm. 10, pp. 2094-2103
2004
-
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma
Biology of Blood and Marrow Transplantation, Vol. 10, Núm. 10, pp. 698-708